Top Markets
Coin of the day
Quest PharmaTech Inc. Quest PharmaTech Inc.

Quest PharmaTech Inc.

QPTFF
주식 순위 #35835
Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm,... Quest PharmaTech Inc. (QPTFF), an Edmonton, Canada-based pharmaceutical firm, specializes in creating antibody-driven immunotherapeutic remedies primarily for various cancers. A cornerstone of its product pipeline is Mab AR 9.6, an advanced therapeutic candidate specifically designed to target truncated O-glycans on MUC16 for precise cancer treatment applications. The company's offerings further encompass Oregovomab, an anti-CA-125 antibody that has successfully completed Phase II clinical trials for the management of ovarian cancer. Beyond these specific agents, Quest PharmaTech is actively involved in the development, manufacturing, and commercialization of new immunotherapy products aimed at combating pancreatic cancer. The organization also diversifies its portfolio by utilizing proprietary transdermal delivery technologies to formulate products for dermatological conditions and wound healing. Additionally, it develops specialized skin-penetrating active molecules for use in both cosmetic and pharmaceutical goods. Rounding out its innovative efforts, Quest PharmaTech designs intricate combinatorial immunotherapies for cancer, employing monoclonal antibodies belonging to both immunoglobulin G and E classes.
주가
$0.02
마지막 동기화: 2026-08-13
시가총액
$3.38M
변동 (1일)
0.00%
변동 (1년)
50.38%
국가
CA
거래 Quest PharmaTech Inc. (QPTFF)

카테고리

Quest PharmaTech Inc. (QPTFF)의 EPS
2026 기준 EPS TTM: 0
Quest PharmaTech Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Quest PharmaTech Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS